Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer

BACKGROUND: Progesterone receptor (PgR) negative breast cancer (BC) is an aggressive subtype with poor prognosis and reduced response to endocrine treatments. Several studies have suggested that androgen receptor (AR) expression is associated with a favorable tumor biology, longer recurrence free su...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ther Adv Med Oncol
Main Authors: Tagliaferri, Barbara, Quaquarini, Erica, Palumbo, Raffaella, Balletti, Emanuela, Presti, Daniele, Malovini, Alberto, Agozzino, Manuela, Teragni, Cristina Maria, Terzoni, Andrea, Bernardo, Antonio, Villani, Laura, Sottotetti, Federico
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2020
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7502860/
https://ncbi.nlm.nih.gov/pubmed/32994808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920958355
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki